» Articles » PMID: 25200050

Long-term Results (≤18 Years) of the Edge-to-edge Mitral Valve Repair Without Annuloplasty in Degenerative Mitral Regurgitation: Implications for the Percutaneous Approach

Overview
Journal Circulation
Date 2014 Sep 10
PMID 25200050
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Background: To assess the long-term results of the edge-to-edge mitral repair performed without annuloplasty in degenerative mitral regurgitation (MR).

Methods And Results: From 1993 to 2002, 61 patients with degenerative MR were treated with an isolated edge-to-edge suture without any annuloplasty. Annuloplasty was omitted in 36 patients because of heavy annular calcification and in 25 for limited annular dilatation. A double-orifice repair was performed in 53 patients and a commissural edge-to-edge in 8. Hospital mortality was 1.6%. Follow-up was 100% complete (mean length, 9.2±4.21 years; median, 9.7; longest, 18.1). Survival at 12 years was 51.3±7.75%. At the last echocardiographic examination, MR ≥3+ was demonstrated in 33 patients (55%). At 12 years, freedom from reoperation was 57.8±7.21% and freedom from recurrence of MR ≥3+ was 43±7.6%. Residual MR >1+ at hospital discharge was identified as a risk factor for recurrence of MR ≥3+ (hazard ratio, 3.8; 95% confidence interval, 1.7-8.2; P=0.001). In patients with residual MR ≤1+ immediately after surgery, freedom from MR ≥3+ at 5 and 10 years was 80±6% and 64±7.58%, respectively.

Conclusions: In degenerative MR, the overall long-term results of the surgical edge-to-edge technique without annuloplasty are not satisfactory. Early optimal competence (residual MR ≤1+) was associated with higher freedom from recurrent severe regurgitation.

Citing Articles

A Novel Transcatheter Posterior Ventricular Anchoring Neochordoplasty Mitral Valve Repair Device.

Park M, Imbrie-Moore A, Paulsen M, Zhu Y, MacArthur J, Woo Y Cardiovasc Eng Technol. 2024; .

PMID: 39724314 DOI: 10.1007/s13239-024-00764-9.


Survival and Durability of Minimally Invasive Mitral Valve Repair: Insights from Different Repair Techniques.

Iaccarino A, Giambuzzi I, Galbiati D, Cuko E, Droandi G, Forcina S Med Sci (Basel). 2024; 12(3).

PMID: 39311159 PMC: 11417822. DOI: 10.3390/medsci12030046.


Transcatheter Treatment Options for Functional Mitral Regurgitation: Which Device for Which Patients?.

Tom S, Kalra K, Perdoncin E, Tully A, Devireddy C, Inci E Interv Cardiol. 2024; 19:e10.

PMID: 39081829 PMC: 11287627. DOI: 10.15420/icr.2021.29.


Mid-term outcomes of surgical aortic valve replacement using a mosaic porcine bioprosthesis with concomitant mitral valve repair.

Sugimori H, Nakao T, Okada Y, Okita Y, Yaku H, Kobayashi J Heart Vessels. 2023; 39(3):252-265.

PMID: 37843552 DOI: 10.1007/s00380-023-02325-x.


Feasibility and Outcomes of Mitral Transcatheter Edge-To-Edge Repair in Patients With Variable Degrees of Mitral Annular Calcification.

Hatab T, Bou Chaaya R, Zaid S, Wessly P, Satish P, Villanueva V J Am Heart Assoc. 2023; 12(19):e031118.

PMID: 37753800 PMC: 10727232. DOI: 10.1161/JAHA.123.031118.